An Individual Segmented Trajectory Approach for Identifying Opioid Use Patterns Using Longitudinal Dispensing Data

Overview

Journal Pharmacoepidemiol Drug Saf

Publisher Wiley

Specialties Pharmacology
Public Health

Date 2023 Oct 10

PMID 37814576

Authors

Stanley Xu

Komal J Narwaney

Anh P Nguyen

Ingrid A Binswanger

David L McClure

Jason M Glanz

Affiliations

Soon will be listed here.

Abstract

Purpose: The aim of this study is to use electronic opioid dispensing data to develop an individual segmented trajectory approach for identifying opioid use patterns. The resulting opioid use patterns can be used for examining the association between opioid use and drug overdose.

Methods: We retrospectively assembled a cohort of members on long-term opioid therapy (LTOT) between January 1, 2006 and June 30, 2019 who were 18 years and older and enrolled in one of three health care systems in the US. We have developed an individual segmented trajectory analysis for identifying various opioid use patterns by scanning over the follow-up and finding distinct opioid use patterns based on variability measured with coefficient of variation and trends of milligram morphine equivalents levels.

Results: Among 31, 865 members who were on LTOT between January 1, 2006 and June 30, 2019, 58.3% were female, and the average age was 55.4 years (STD = 15.4). The study population had 152 557 person-years of follow-up, with an average follow-up of 4.4 years per enrollment per person (STD = 3.4). This novel approach identified up to 13 distinct patterns including 88 756 episodes of "stable" pattern (42.1%) with an average follow-up of 11.2 months, 29 140 episodes of "increasing" pattern (13.8%) with an average follow-up of 6.0 months, 13 201 episodes of ≤10% dose reduction (6.3%) with an average follow-up of 10.4 months, 7286 episodes of 11%-20% dose reduction (3.5%) with an average follow-up of 5.3 months, 4457 episodes of 21%-30% dose reduction (2.1%) with an average follow-up of 4.0 months, and 9903 episodes of >30% dose reduction (4.7%) with an average follow-up of 2.6 months.

Conclusions: A novel approach was developed to identify 13 distinct opioid use patterns using each individual's longitudinal dispensing data and these patterns can be used in examining overdose risk during the time that these patterns are ongoing.

References

Leino A, King E, Jiang W, Vinks A, Klawitter J, Christians U . Assessment of tacrolimus intrapatient variability in stable adherent transplant recipients: Establishing baseline values. Am J Transplant. 2018; 19(5):1410-1420. DOI: 10.1111/ajt.15199. View

France E, Glanz J, Xu S, Hambidge S, Yamasaki K, Black S . Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children. Pediatrics. 2008; 121(3):e687-92. DOI: 10.1542/peds.2007-1578. View

Wei Y, Chen C, Lewis M, Schmidt S, Winterstein A . Trajectories of prescription opioid dose and risk of opioid-related adverse events among older Medicare beneficiaries in the United States: A nested case-control study. PLoS Med. 2022; 19(3):e1003947. PMC: 8923459. DOI: 10.1371/journal.pmed.1003947. View

Ko H, Kim H, Chung C, Han A, Min S, Ha J . Association between medication adherence and intrapatient variability in tacrolimus concentration among stable kidney transplant recipients. Sci Rep. 2021; 11(1):5397. PMC: 7940492. DOI: 10.1038/s41598-021-84868-5. View

Mark T, Parish W . Opioid medication discontinuation and risk of adverse opioid-related health care events. J Subst Abuse Treat. 2019; 103:58-63. DOI: 10.1016/j.jsat.2019.05.001. View

Compton W, Jones C, Baldwin G . Relationship between Nonmedical Prescription-Opioid Use and Heroin Use. N Engl J Med. 2016; 374(2):154-63. PMC: 11784537. DOI: 10.1056/NEJMra1508490. View

Nagarwalla N . A scan statistic with a variable window. Stat Med. 1996; 15(7-9):845-50. DOI: 10.1002/(sici)1097-0258(19960415)15:7/9<845::aid-sim254>3.0.co;2-x. View

Dunn K, Saunders K, Rutter C, Banta-Green C, Merrill J, Sullivan M . Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010; 152(2):85-92. PMC: 3000551. DOI: 10.7326/0003-4819-152-2-201001190-00006. View

Glanz J, McClure D, Xu S, Hambidge S, Lee M, Kolczak M . Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. J Clin Epidemiol. 2006; 59(8):808-18. DOI: 10.1016/j.jclinepi.2005.11.012. View

10.

Oliva E, Bowe T, Manhapra A, Kertesz S, Hah J, Henderson P . Associations between stopping prescriptions for opioids, length of opioid treatment, and overdose or suicide deaths in US veterans: observational evaluation. BMJ. 2020; 368:m283. PMC: 7249243. DOI: 10.1136/bmj.m283. View

11.

Farrington C . Relative incidence estimation from case series for vaccine safety evaluation. Biometrics. 1995; 51(1):228-35. View

12.

Dowell D, Ragan K, Jones C, Baldwin G, Chou R . CDC Clinical Practice Guideline for Prescribing Opioids for Pain - United States, 2022. MMWR Recomm Rep. 2022; 71(3):1-95. PMC: 9639433. DOI: 10.15585/mmwr.rr7103a1. View

13.

Glanz J, Binswanger I, Shetterly S, Narwaney K, Xu S . Association Between Opioid Dose Variability and Opioid Overdose Among Adults Prescribed Long-term Opioid Therapy. JAMA Netw Open. 2019; 2(4):e192613. PMC: 6481879. DOI: 10.1001/jamanetworkopen.2019.2613. View

14.

Nataraj N, Strahan A, Guy Jr G, Losby J, Dowell D . Dose tapering, increases, and discontinuity among patients on long-term high-dose opioid therapy in the United States, 2017-2019. Drug Alcohol Depend. 2022; 234:109392. PMC: 9635453. DOI: 10.1016/j.drugalcdep.2022.109392. View

15.

DiPrete B, Ranapurwala S, Maierhofer C, Fulcher N, Chelminski P, Ringwalt C . Association of Opioid Dose Reduction With Opioid Overdose and Opioid Use Disorder Among Patients Receiving High-Dose, Long-term Opioid Therapy in North Carolina. JAMA Netw Open. 2022; 5(4):e229191. PMC: 9047650. DOI: 10.1001/jamanetworkopen.2022.9191. View

16.

Wei Y, Chen C, Fillingim R, Schmidt S, Winterstein A . Trends in prescription opioid use and dose trajectories before opioid use disorder or overdose in US adults from 2006 to 2016: A cross-sectional study. PLoS Med. 2019; 16(11):e1002941. PMC: 6830744. DOI: 10.1371/journal.pmed.1002941. View

17.

Agnoli A, Xing G, Tancredi D, Magnan E, Jerant A, Fenton J . Association of Dose Tapering With Overdose or Mental Health Crisis Among Patients Prescribed Long-term Opioids. JAMA. 2021; 326(5):411-419. PMC: 8335575. DOI: 10.1001/jama.2021.11013. View

18.

Glanz J, Xu S, Narwaney K, McClure D, Rinehart D, Ford M . Association Between Opioid Dose Reduction Rates and Overdose Among Patients Prescribed Long-Term Opioid Therapy. Subst Abus. 2023; 44(3):209-219. PMC: 11044711. DOI: 10.1177/08897077231186216. View

19.

Binswanger I, Shetterly S, Xu S, Narwaney K, McClure D, Rinehart D . Opioid Dose Trajectories and Associations With Mortality, Opioid Use Disorder, Continued Opioid Therapy, and Health Plan Disenrollment. JAMA Netw Open. 2022; 5(10):e2234671. PMC: 9535531. DOI: 10.1001/jamanetworkopen.2022.34671. View

20.

Xu S, Zhang L, Nelson J, Zeng C, Mullooly J, McClure D . Identifying optimal risk windows for self-controlled case series studies of vaccine safety. Stat Med. 2011; 30(7):742-52. DOI: 10.1002/sim.4125. View